SCHEMBL3155176

SCHEMBL3155176

COCc1cc2ccccc2cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2A6 P11509 1/20 0.48
▸ PDE10A Q9Y233 4/20 0.48
▸ ATM Q13315 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ PDPK1 O15530 1/20 0.44
▸ POLB P06746 1/20 0.41
▸ KDM4C Q9H3R0 1/20 0.40
▸ GABRA1 P14867 1/20 0.39
▸ GABRG2 P18507 1/20 0.39
▸ GABRB3 P28472 1/20 0.39
▸ GABRA5 P31644 1/20 0.39
▸ GABRA3 P34903 1/20 0.39
▸ GABRA2 P47869 1/20 0.39
▸ PIK3CD O00329 1/20 0.38
▸ PIK3CA P42336 1/20 0.38
▸ PIK3CB P42338 1/20 0.38
▸ PI4KA P42356 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11389023 0.81 ATM (0.53) CYP1A2CYP2A6PDE10AATML3MBTL1
SCHEMBL11322378 0.81 PDE10A (0.46) CYP1A2CYP2A6PDE10AATML3MBTL1
SCHEMBL10544101 0.81 KCNH2 (0.60) CYP1A2CYP2A6PDE10AATML3MBTL1
SCHEMBL11395049 0.79 PDE10A (0.44) CYP1A2CYP2A6PDE10AATML3MBTL1
SCHEMBL14479273 0.79 L3MBTL1 (0.45) CYP1A2CYP2A6PDE10AL3MBTL1PIK3CD
SCHEMBL873512 0.78 CYP1A2 (0.54) CYP1A2CYP2A6PDE10AATML3MBTL1
SCHEMBL10667109 0.78 ALDH1A1 (0.47) CYP1A2CYP2A6PDE10AATML3MBTL1
SCHEMBL18103467 0.78 CYP1A2 (0.41) CYP1A2CYP2A6PDE10APOLBPIK3CD
SCHEMBL28931171 0.77 ATM (0.44) CYP1A2CYP2A6PDE10AATML3MBTL1
SCHEMBL11371036 0.76 PDE10A (0.44) CYP1A2PDE10ANPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1555257-B1 PROCESS FOR PRODUCING AROMATIC NITRILE COMPOUND IHARA CHEMICAL IND CO (JP) 2010-01-20 — — EP disclosed
CN-100339360-C Process for producing aromatic nitrile compound IHARA CHEMICAL IND CO (JP) 2007-09-26 — — CN disclosed
US-7262316-B2 Process for producing aromatic nitrile compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2007-08-28 — — US disclosed
US-20060069282-A1 Process for producing aromatic nitrile compound IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2006-03-30 — — US disclosed
CN-1714074-A Method for producing aromatic nitrile compound IHARA CHEMICAL IND CO (JP) 2005-12-28 — — CN disclosed
EP-1555257-A1 PROCESS FOR PRODUCING AROMATIC NITRILE COMPOUND IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) 2005-07-20 — — EP disclosed
US-4287197-A ALSO USEFUL AS ANALGESICS, ANTIPYRETICS AND ANTIINFLAMMATORY AGENTS RHONE-POULENC INDUSTRIES (FR) 1981-09-01 — — US disclosed
US-4261992-A ANALGESIC, ANTIINFLAMMATORY, ANTIPYRETIC RHONE POULENC INDUSTRIES (FR) 1981-04-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069282-A1 Process for producing aromatic nitrile compound ODC1, ALKBH3, GNMT CYP1A2 219/4885CYP2A6 2434/4885PDE10A 3001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback